Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United Sta...
Web of Science
Web of Science
FR
CHATENAY M.-PARIS 11-BU Pharma. (920192101) / Sudoc / Sudoc / France / FR
Published in Emerging Infectious Diseases
Published in The Journal of antimicrobial chemotherapy
The current beta-lactamase classifications have reached a high level of complexity, making them less accessible to clinicians, infection control professionals, hospital management and politicians. From the clinical perspective, a revised comprehensible nomenclature scheme is therefore needed. The term extended-spectrum beta-lactamases (ESBLs) has r...
Published in The Journal of infection
Starting in May 2007, an ongoing outbreak of infections due to carbapenem resistant KPC-2-producing Klebsiella pneumoniae occurred in a tertiary care hospital in Crete (Greece). The outbreak involved 22 patients, none of whom had travelled in a country with known high prevalence of such isolates. KPC-producing K. pneumoniae strains were mainly isol...
Published in Diagnostic microbiology and infectious disease
Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae may appear susceptible to imipenem or meropenem by routine susceptibility testing. We report a series of patients with infections caused by K. pneumoniae isolates, which yielded imipenem-susceptible results but were subsequently KPC-positive by polymerase chain reaction. When these i...
Web of Science
Les carbapénèmes, b-lactamines possédant le spectre d activité le plus large, sont souvent la dernière option thérapeutique des infections sévères dues à des germes multi-résistants. Les entérobactéries résistantes aux carbapénèmes, bien que rares en France, sont épidémiques voir même endémiques dans de nombreux pays. Cette résistance est principal...
FR